CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K/A Event Shareholder vote results
- 4 Open-market sale Chief Executive Officer sold 15,502 shares at an average $3.20 ($49,620)
- 4 Open-market sale Chief Medical Officer sold 6,783 shares at an average $3.20 ($21,697)
- 4 Open-market sale Chief Financial Officer sold 11,635 shares at an average $3.20 ($37,194)
- 8-K Event Shareholder vote results
- 4 Grant or award Director acquired 13,851 shares (grant or award)
- 4 Grant or award Director acquired 13,671 shares (grant or award)
- 4 Grant or award Director acquired 13,671 shares (grant or award)
- 4 Grant or award Director acquired 13,671 shares (grant or award)
- 4 Grant or award Director acquired 13,671 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- DFAN14A Other Proxy Soliciting Materials
- DFAN14A Other Proxy Soliciting Materials
Page 14 of 26 · 506 filings